Dyne Therapeutics Inc (NASDAQ: DYN) is -73.82% lower on its value in year-to-date trading and has touched a low of $6.36 and a high of $47.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DYN stock was last observed hovering at around $8.88 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $8.8, the stock is -16.27% and -23.57% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.01 million and changing -0.90% at the moment leaves the stock -52.92% off its SMA200. DYN registered -62.65% loss for a year compared to 6-month loss of -64.18%. The firm has a 50-day simple moving average (SMA 50) of $11.5141 and a 200-day simple moving average (SMA200) of $18.692125.
The stock witnessed a -38.89% gain in the last 1 month and extending the period to 3 months gives it a 29.22%, and is -1.57% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.76% over the week and 7.22% over the month.
Dyne Therapeutics Inc (DYN) has around 191 employees, a market worth around $1.25B and $0.00M in sales. Distance from 52-week low is 38.36% and -81.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.42%).
The EPS is expected to shrink by -16.12% this year
281.0 institutions hold shares in Dyne Therapeutics Inc (DYN), with institutional investors hold 110.86% of the company’s shares. The shares outstanding are 113.63M, and float is at 106.14M with Short Float at 19.43%. Institutions hold 110.24% of the Float.
The top institutional shareholder in the company is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with over 8.02 million shares valued at $283.03 million. The investor’s holdings represent 8.6697 of the DYN Shares outstanding. As of 2024-06-30, the second largest holder is FCPM III SERVICES B.V. with 7.85 million shares valued at $276.86 million to account for 8.4808 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 7.39 million shares representing 7.9853 and valued at over $260.69 million, while RTW INVESTMENTS, LP holds 6.9044 of the shares totaling 6.39 million with a market value of $225.4 million.
Dyne Therapeutics Inc (DYN) Insider Activity
Still, SEC filings show that on Jun 05 ’25, Cox John (CEO & President) disposed off 4,060 shares at an average price of $13.35 for $54201.0. The insider now directly holds 142,179 shares of Dyne Therapeutics Inc (DYN).
